Tyrosine kinase receptor RON and its ligand MSP in Merkel cell carcinoma

Pathology Research and Practice

Volumn 207, Issue 8, 2011, Pages 463-467

  Nagahama, Junji ^a   Daa, Tsutomu ^a   Yada, Naomi ^a   Kashima, Kenji ^a   Fujiwara, Sakuhei ^a   Saikawa, Tetsunori ^a   Yokoyama, Shigeo ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Merkel cell carcinoma; MSP; Pathogenesis; RON

Indexed keywords

MACROPHAGE ACTIVATING FACTOR; TYROSINE KINASE RECEPTOR; TYROSINE KINASE RECEPTOR RON; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; MALE; MERKEL CELL TUMOR; MISSENSE MUTATION; MSP GENE; MUTATIONAL ANALYSIS; ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RON GENE; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA, MERKEL CELL; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MALE; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 80051799839     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.05.006     Document Type: Article

References (24)

1. Angeloni D., Danilkovitch-Miagkova A., Ivanov S.V., et al. Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples. Genes Chromosomes Cancer 2000, 29:147-156.
2. Asioli S., Righi A., Volante M., Eusebi V., Bussolati G. p63 expression as a new prognostic marker in Merkel cell carcinoma. Cancer 2007, 110:640-647.
3. Becker J.C., Schrama D., Houben R. Merkel cell carcinoma. Cell Mol. Life Sci. 2009, 66:1-8.
4. Camp E.R., Liu W., Fan F., Yang A., Somcio R., Ellis L.M. RON, a tyrosine kinase receptor involved in tumor progression and metastasis. Ann. Surg. Oncol. 2005, 12:273-281.
5. Danilkovitch-Miagkova A. Oncogenic signaling pathways activated by RON receptor tyrosine kinase. Curr. Cancer Drug Targets 2003, 3:31-40.
6. Danilkovitch-Miagkova A., Miagkov A., Skeel A., Nakaigawa N., Zbar B., Leonard E.J. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway. Mol. Cell Biol. 2001, 21:5857-5868.
7. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-1100.
8. Gaudino G., Avantaggiato V., Follenzi A., Acampora D., Simeone A., Comoglio P.M. The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. Oncogene 1995, 11:2627-2637.
9. Gaudino G., Follenzi A., Naldini L., et al. RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J. 1994, 13:3524-3532.
10. Houben R., Michel B., Vetter-Kauczok C.S., et al. Absence of classical MAP kinase pathway signalling in Merkel cell carcinoma. J. Invest. Dermatol. 2006, 126:1135-1142.
11. Kartha R.V., Sundram U.N. Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis. Mod. Pathol. 2008, 21:96-104.
12. Leonard J.H., Williams G., Walters M.K., Nancarrow D.J., Rabbitts P.H. Deletion mapping of the short arm of chromosome 3 in Merkel cell carcinoma. Genes Chromosomes Cancer 1996, 15:102-107.
13. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989, 5:874-879.
14. Peace B.E., Hughes M.J., Degen S.J., Waltz S.E. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Oncogene 2001, 20:6142-6151.
15. Porter A.C., Vaillancourt R.R. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene 1998, 17:1343-1352.
16. Robertson S.C., Tynan J.A., Donoghue D.J. RTK mutations and human syndromeswhen good receptors turn bad. Trends Genet. 2000, 16:265-271.
17. Ronsin C., Muscatelli F., Mattei M.G., Breathnach R. A novel putative receptor protein tyrosine kinase of the met family. Oncogene 1993, 8:1195-1202.
18. Santoro M.M., Penengo L., Minetto M., Orecchia S., Cilli M., Gaudino G. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor. Oncogene 1998, 17:741-749.
19. Van Gele M., Kaghad M., Leonard J.H., et al. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br. J. Cancer 2000, 82:823-826.
20. Van Gele M., Leonard J.H., Van Roy N., et al. Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma. Int. J. Cancer 2002, 101:137-145.
21. Wang M.H., Wang D., Chen Y.Q. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase. Carcinogenesis 2003, 24:1291-1300.
22. Wang M.H., Yao H.P., Zhou Y.Q. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers. Acta Pharmacol. Sin. 2006, 27:641-650.
23. Worda M., Sreevidya C.S., Ananthaswamy H.N., Cerroni L., Kerl H., Wolf P. T1796A BRAF mutation is absent in Merkel cell carcinoma. Br. J. Dermatol. 2005, 153:229-232.
24. Yoshimura T., Yuhki N., Wang M.H., Skeel A., Leonard E.J. Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J. Biol. Chem. 1993, 268:15461-15468.